Localization of the long form of beta-1,4-galactosyltransferase to the plasma membrane and Golgi complex of 3T3 and F9 cells by immunofluorescence confocal microscopy
- PMID: 7971983
- PMCID: PMC45136
- DOI: 10.1073/pnas.91.23.10913
Localization of the long form of beta-1,4-galactosyltransferase to the plasma membrane and Golgi complex of 3T3 and F9 cells by immunofluorescence confocal microscopy
Abstract
beta-1,4-Galactosyltransferase (GalTase) is localized to two subcellular compartments, the Golgi complex, where it participates in cellular glycosylation, and the plasma membrane, where it functions as a receptor for oligosaccharide ligands on opposing cells or in the extracellular matrix. The gene for GalTase encodes two nearly identical proteins that differ only in their N-terminal cytoplasmic domains: both short and long GalTases share an 11-aa cytoplasmic tail, but long GalTase has an additional 13-aa sequence on its cytoplasmic domain. In this study, we investigated the subcellular distribution of endogenous long GalTase in untransfected F9 and 3T3 cells by using confocal microscopy and antibodies specific for the 13-aa sequence unique to long GalTase. Long GalTase was found in the Golgi complex as expected; long GalTase was also found on the plasma membrane in cell-type-specific distributions. In 3T3 cells, long GalTase was evident on the basal surface of cells possessing a migratory phenotype, being concentrated at the leading and trailing edges; nonmigratory cells had little detectable surface immunoreactivity. In F9 cells, long GalTase was localized on the plasma membrane, being concentrated at the apical aspect of intercellular junctions. These results demonstrate that in 3T3 and F9 cells, long GalTase is present on the cell surface in addition to the Golgi complex. The pattern of surface expression shows cell-type specificity that is consistent with GalTase function in cellular interactions.
Similar articles
-
Cell surface and Golgi pools of beta-1,4-galactosyltransferase are differentially regulated during embryonal carcinoma cell differentiation.Mol Cell Biol. 1989 Jun;9(6):2370-7. doi: 10.1128/mcb.9.6.2370-2377.1989. Mol Cell Biol. 1989. PMID: 2503706 Free PMC article.
-
Dominant negative mutation in cell surface beta 1,4-galactosyltransferase inhibits cell-cell and cell-matrix interactions.J Cell Biol. 1993 Feb;120(4):1045-57. doi: 10.1083/jcb.120.4.1045. J Cell Biol. 1993. PMID: 8432725 Free PMC article.
-
Evidence for a molecular distinction between Golgi and cell surface forms of beta 1,4-galactosyltransferase.J Biol Chem. 1991 Aug 25;266(24):15984-91. J Biol Chem. 1991. PMID: 1714903
-
Targeted mutations in beta1,4-galactosyltransferase I reveal its multiple cellular functions.Biochim Biophys Acta. 2002 Dec 19;1573(3):258-70. doi: 10.1016/s0304-4165(02)00392-6. Biochim Biophys Acta. 2002. PMID: 12417408 Review.
-
Biological consequences of targeting beta 1,4-galactosyltransferase to two different subcellular compartments.Bioessays. 1995 Mar;17(3):261-8. doi: 10.1002/bies.950170313. Bioessays. 1995. PMID: 7748180 Review.
Cited by
-
High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia.Front Genet. 2022 Dec 9;13:882004. doi: 10.3389/fgene.2022.882004. eCollection 2022. Front Genet. 2022. PMID: 36568388 Free PMC article.
-
Transition of galactosyltransferase 1 from trans-Golgi cisterna to the trans-Golgi network is signal mediated.Mol Biol Cell. 2006 Dec;17(12):5153-62. doi: 10.1091/mbc.e06-08-0665. Epub 2006 Oct 4. Mol Biol Cell. 2006. PMID: 17021253 Free PMC article.
-
Expression of natural human β1,4-GalT1 variants and of non-mammalian homologues in plants leads to differences in galactosylation of N-glycans.Transgenic Res. 2014 Oct;23(5):717-28. doi: 10.1007/s11248-014-9806-z. Epub 2014 Aug 1. Transgenic Res. 2014. PMID: 25082356
-
β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway.Cancer Res Treat. 2020 Oct;52(4):1084-1102. doi: 10.4143/crt.2020.093. Epub 2020 May 27. Cancer Res Treat. 2020. PMID: 32599982 Free PMC article.
-
Ginsenoside 20(S)-Rg3 Hinders Esophageal Squamous Cell Carcinoma Cells Malignant Behaviors by miR-210-3p/B4GALT5 Axis.Cell Biochem Biophys. 2025 Jun;83(2):1555-1563. doi: 10.1007/s12013-024-01566-5. Epub 2024 Oct 18. Cell Biochem Biophys. 2025. PMID: 39422791
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous